Bernhard Keppler Metallhaltige Verbindungen in der Krebstherapie 2005 GDCh-Kolloquium Giessen invited speaker

Transkript

1 Metallhaltige Verbindungen in der Krebstherapie 2005 GDCh-Kolloquium Giessen Bernhard K. Keppler Metal Coordination Compounds in Cancer Therapy 2005 Younger European Chemists's Conference in Brno SET for Europe, Brno 2005 New Antitumor-Active Metal Complexes, Preclinical Development and Clinical Experience Gordon Research GRC, Oxford Bernhard K. Keppler, Development of a new metal compound as antitumor drugs From bench to bedside ASBIC3, Nanjing China, keynote Entwicklung neuer tumorhemmender Metallkomplexe: von der Synthese bis zur Klinik Kolloquium der Chemischen Gesellschaft in Heidelberg, Metal Coordination Compounds in Cancer Therapy Future Perspectives workshop on Metal Based Drugs, Jerusalem, Antitumor Active Metal Compounds Sstrategies to Overcome Resistance. Forschergruppe "Biologische Funktion von Organometallverbindungen" Berlin, NOVEL STRATEGIES TO DEVELOP NEW ANTITUMOR-ACTIVE METAL COMPOUNDS FIGIPAS 07, Wien, Development of New Antitumor Compounds New Aspects 2nd ECCLSc, Wrclaw,

2 Preclinical Status and Clinical Development of New Non-Platinum Antitumor Drugs Verona, X ISPCC (International Symposiumon Platinum Coordination Compounds in Cancer Chemotherapy) The Development of Anticancer Active Coordination Compounds Chemistry and Cancer Meeting, University College Dublin, 15.Febr Bioanorganische Entwicklung neuer Chemotherapeutika Arzneimittelforums der klinischen Pharmakologie, MUW Wien, Mai 2008 Beyond Platinum: Investigational Metallodrugs for Cancer Therapy Eurobic, Wrclaw, September 2008 keynote Development of New Anticancer Metal Complexes - from Bench to Bedside Universität Siena, Juni 2008 Anticancer-Active Coordination Compounds - New Strategies Seminar ETH Zürich, Mai 2008 Tumor Therapy Based on Inorganic Compounds COST D39, Universität Leiden, Nov 2008 Expanding the metal-based armamentarium for cancer therapy COST Meeting, Irbid /Jordanien, Organometallic Complexes Containing Sulfur or Selenium Ligands, Oktober 2008 Von der Koordinationschemie zur Entwicklung neuer Krebstherapeutika COST D29 WG Meeting /Universität Jena, 9. Juli 2009

3 Tumor-inhibiting Metal Compounds from Bench to Bedside Nawi Tag Graz, 26. Juni 2009 Die Rolle der Koordinationschemie in der modernen Medizin am Beispiel neuer Krebstherapeutika Universität München, 9.Juli 2009 Wiberg Vorlesung Neue koordinationschemische Strategien zur Entwicklung von Tumortherapeutika GÖCH Kolloquium Universität Linz,

4 Entwicklung neuer antitumoraler Metallkomplexe Jahrestagung 2010 der Deutschen Pharmazeutischen Gesellschaft, Braunschweig Deutschland, Recent Developments in Investigational Metal-Based Cancer Therapeutics 10th European Biological Inorganic Chemistry Conference, Thessaloniki, Greece, Pre-clinical and clinical development of ruthenium and gallium compounds an overview and update Ce-M-M- Austrodrugs Research Center for Molecular Medicine of the Austrian Academy of Sciences invited lecture Combating Cancer with Metal Compounds - Approaches and Perspectives First EuCheMS Inorganic Chemistry Conference (EICC-1) Manchester, England, Technologietransfer an der Universität Wien Inits-Veranstaltung (Universitäres Gründerservice GmbH) Konzept Innovation goes Business 2011, Vortrag Univ Wien From coordination compounds to anticancer drugs Metallomics 2011, Münster, Germany, Investigational Metal-Based Cancer Therapeutics Recent Developments 15th International Conference on Biological Inorganic Chemistry (ICBIC 15) Vancouver, Canada, Invited lecture Metalle in der Medizin. Von metallhaltigen Enzymen bis zu neuen Krebstherapeutika. Wiener Vorlesungen im Rahmen des Jahres der Chemie, Wiener Vorlesung Univ Wien

5 Metallkomplexe in der Krebstherapie Gibt es eine Zukunft für Ruthenium in der klinischen Therapie bösartiger Tumoren? Vortrag an Univ Gießen Gießen, Deutschland am Recent Advances with Ruthenium Compounds in Cancer Treatment 1st Russian Conference on Medicinal Chemistry" Moskau, Russland am Preclinical and Clinical Development of an Antitumor Ruthenium Compound (Update) Austro Drugs Meeting, CeMM Forschungszentrum f Molekulare Medizin GmbH - d Österr. Akademie d Wissenschaften Wien, invited speaker Metal Complexes and Organometallic, Compounds in Anticancer Drug Development XI Congress of the Interdivisional Group of Organometallic Chemistry (XI Co.G.I.C.O.) Mailand, Italien, Recent Advances in Bioinorganic Anticancer Drug Development 12th European Biological Inorganic Chemistry Conference (EUROBIC 12) Zürich, Development of Metal-based Anticancer Drugs in the Era of Targeted Therapies 13th International Symposium on Applied Bioinorganic Chemistry ISABC13 NUI Galway Anticancer Metal Compounds in the Era of Targeted Therapies: Challenges and Approaches GDCh Kolloquium Universität Bremen Bremen,